Xenobiotic transporters are responsible for the uptake of some chemicals into cells, and extremely important for the export of chemicals out of cells. A number of families of xenobiotic transporters have been cloned the last few years. Some microsomal enzyme inducers will enhance the plasma disappearance and biliary excretion of some xenobiotics that are not biotransformed in the intact animal, as well as in isolated hepatocytes. This is due to an up-regulation of xenobiotic transporters. As a result, some microsomal enzyme inducers will enhance the elimination and decrease the toxicity of some chemicals by enhanced transport.
Eaton, D. L., and CD. Klaassen.1979. Effects of microsomal enzyme inducers on carrier-mediated transport systems in isolated rat hepatocytes. J. Pharmacol. Exp. Ther.208:381–385.
2.
Endicott, J. A., and V. Ling.1989. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem.58:137–171.
3.
Gottesman, M. M., and I. Pastan.1993. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem.62:385–427.
4.
Klaassen, C. D.1970. Plasma disappearance and biliary excretion of sulfobromophthalein and phenol-3,6-dibromophthalein disulfate after microsomal enzyme induction. Biochem. Pharmacol.19:1241–1249.
5.
Klaassen, C. D.1974. Effect of microsomal enzyme inducers on the biliary excretion of cardiac glycosides. J. Pharmacol. Exp. Ther.191:201–211.
6.
Klaassen, C. D., and G. L. Plaa.1968. Studies on the mechanism of phenobarbital-enhanced sulfobromophthalein disappearance. J. Pharmacol. Exp. Ther.161:361–366.
7.
Ling, V. 1997. Multidrug resistance: Molecular mechanisms and clinical relevance. Cancer Chemother. Pharmacol.40:S3–S8.
8.
Rausch-Derra, L., D. P. Hartley, P. J. Meier, and C. D. Klaassen.2001. Differential effects of microsomal enzyme-inducing chemicals on the hepatic expression of rat organic anion transporters, oatp1 and oatp2. Hepatology33:1469–1478.
9.
Schinkel, A. H., J. J. M. Smit, O. van Tellingen, J. H. Beijnen, E. Wagenaar, L. van Deemter, C. A. A. M. Mol, M. A. van der Vali, E. C. Robanus-Maandag, H. P. J. te Riele, A. J. M. Berns, and P. Borst.1994. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell77:491–502.